GGrantIndex
← Search

Cancer Center Support Grant

$85,742P30FY2025CANIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07339085Trial NCT07276438Trial NCT07242365Trial NCT06650163Trial NCT06568016Trial NCT06113016Trial NCT05595499Trial NCT04205838Trial NCT04201873Trial NCT04185311Trial NCT04119024Trial NCT04106362Trial NCT04069923Trial NCT04069910Trial NCT04050215Trial NCT04007029Trial NCT03996850Trial NCT03970252Trial NCT03953157Trial NCT03904251Trial NCT03902951Trial NCT03892720Trial NCT03830918Trial NCT03825796Trial NCT03745690Trial NCT03732950Trial NCT03732352Trial NCT03672773Trial NCT03623854Trial NCT03618134Trial NCT03603223Trial NCT03601455Trial NCT03596710Trial NCT03582774Trial NCT03582475Trial NCT03541850Trial NCT03515577Trial NCT03506802Trial NCT03425461Trial NCT03411070Trial NCT03368547Trial NCT03319342Trial NCT03240861Trial NCT03202472Trial NCT03128619Trial NCT03025139Trial NCT03014804Trial NCT02940262Trial NCT02928510Trial NCT02925351Trial NCT02919332Trial NCT02902757Trial NCT02888301Trial NCT02881242Trial NCT02880020Trial NCT02879994Trial NCT02830165Trial NCT02816879Trial NCT02775292Trial NCT02756130Trial NCT02701153Trial NCT02688348Trial NCT02683200Trial NCT02672033Trial NCT02597894Trial NCT02575027Trial NCT02451865Trial NCT02336763Trial NCT02310594Trial NCT02296229Trial NCT02280161Trial NCT02263898Trial NCT02176902Trial NCT02070406Trial NCT02049593Trial NCT02048020Trial NCT02015559Trial NCT01912820Trial NCT01013285Trial NCT01005472Trial NCT00999557Trial NCT00998010Trial NCT00985192Trial NCT00955591Trial NCT00882765Trial NCT00880542Trial NCT00769470Trial NCT00706615Trial NCT00685516Trial NCT00616642Trial NCT00612066Trial NCT00601289Trial NCT00601094Trial NCT00521209Trial NCT00509431Trial NCT00471887Trial NCT00450567Trial NCT00444223Trial NCT00352001Trial NCT00349167

Abstract

ABSTRACT This application is being submitted in response to "Administrative supplements for research leveraging novel data science approaches to address integration of modifiable risk factors on cancer outcomes". Lung cancer remains the leading cause of cancer-related deaths globally. The Global Burden of Disease 2019 study attributes 62% of lung cancer deaths to smoking, 15% to PM2.5 air pollution, 5.8% to secondhand smoke, and 4% to radon, with additional links to occupational and dietary factors. Existing risk models like PLCOm2012, Bach, and LCRAT incorporate clinical variables such as age, race, BMI, smoking history, and personal/family history of lung cancer. Recent deep learning models, such as Sybil, utilize high-dimensional features from low-dose CT scans and outperform clinical models in predicting up to 6-year risk. However, these models often consider either clinical or imaging-derived features, not both, and typically use linear models like logistic regression, which fail to capture the complex interplay between risk factors. We propose developing and validating a novel data-driven approach to estimate lung cancer risk by integrating clinical, self-reported, and imaging-derived features, incor- porating static and longitudinal information about modifiable risk factors. Our objective is to accurately estimate lung cancer risk changes due to multiple modifiable factors: smoking status, smoking intensity, BMI, and envi- ronmental exposures (e.g., radon, asbestos) from self-reported questionnaires. We hypothesize that using a recurrent neural network to represent the interplay between high-dimensional observable features and changes in risk factors can yield more accurate predictions, further tailoring screening inclusion criteria. Our aims are: (1) develop and validate a recurrent neural network integrating clinical and imaging-derived features using NLST data to predict 6-year lung cancer risk, and (2) validate the risk model using UCLA data and disseminate it to the research community. The data for our proposed model are collected within a 24-hour window, typically reported in questionnaires at the screening exam. The expected outcome will be a data-driven model that jointly incorpo- rates longitudinal changes in smoking status, smoking intensity, body mass index, and environmental factors to predict how intervening on these modifiable risk factors can reduce an individual’s risk of lung cancer.

View original record on NIH RePORTER →